Non-invasive Ventilation in NeuroMuscular Diseases

  • Hariharan Regunath
  • Troy Whitacre
  • Stevan P. Whitt
Chapter

Abstract

Neuromuscular diseases result in respiratory failure due to insufficient ventilation from respiratory muscle weakness. In patients without bulbar affection, non-invasive ventilation (NIV) can be used as an alternative to ventilation, usually via tracheostomy. When used in conjunction with cough assist methods and techniques to sustain and improve clearance of respiratory secretions, NIV can be used both day and night. Mouthpiece ventilation (MPV), also known as sips ventilation, first reported at a post-poliomyelitis respiratory equipment conference in 1953 has also enabled better quality of life. When initiated prior to development of hypercapnia in early myasthenia crisis, NIV decreases the rate of intubation and shortens the duration of hospitalization. Choice of NIV for chronic progressive NMDs must be based on the knowledge and assessment of the ventilatory abnormality for that specific diagnosis.

Keywords

Non-invasive ventilation Neuromuscular disease Respiratory failure Amyotrophic lateral sclerosis Myasthenia gravis 

Notes

Conflict of Interest

None.

References

  1. 1.
    Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218–26.CrossRefGoogle Scholar
  2. 2.
    Benditt JO, Boitano LJ. Pulmonary issues in patients with chronic neuromuscular disease. Am J Respir Crit Care Med. 2013;187(10):1046–55.CrossRefGoogle Scholar
  3. 3.
    Perrin C, Unterborn JN, Ambrosio CD, Hill NS. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve. 2004;29(1):5–27.CrossRefGoogle Scholar
  4. 4.
    Bach JR, Goncalves MR, Hon A, Ishikawa Y, De Vito EL, Prado F, et al. Changing trends in the management of end-stage neuromuscular respiratory muscle failure: recommendations of an international consensus. Am J Phys Med Rehabil. 2013;92(3):267–77.CrossRefGoogle Scholar
  5. 5.
    Aboussouan LS. Sleep-disordered breathing in neuromuscular disease. Am J Respir Crit Care Med. 2015;191(9):979–89.CrossRefGoogle Scholar
  6. 6.
    Rabinstein AA. Noninvasive ventilation for neuromuscular respiratory failure: when to use and when to avoid. Curr Opin Crit Care. 2016;22(2):94–9.PubMedGoogle Scholar
  7. 7.
    Gregoretti C, Pisani L, Cortegiani A, Ranieri VM. Noninvasive ventilation in critically ill patients. Crit Care Clin. 2015;31(3):435–57.CrossRefGoogle Scholar
  8. 8.
    Barrett KE, Barman SM, Boitano S, Brooks HL. Regulation of respiration. Ganong’s review of medical physiology. 25th ed. McGraw-Hill Education: New York; 2016.Google Scholar
  9. 9.
    Shneerson J, Simonds A. Noninvasive ventilation for chest wall and neuromuscular disorders. Eur Respir J. 2002;20(2):480–7.CrossRefGoogle Scholar
  10. 10.
    Ambrosino N, Carpene N, Gherardi M. Chronic respiratory care for neuromuscular diseases in adults. Eur Respir J. 2009;34(2):444–51.CrossRefGoogle Scholar
  11. 11.
    Papastamelos C, Panitch HB, Allen JL. Chest wall compliance in infants and children with neuromuscular disease. Am J Respir Crit Care Med. 1996;154(4 Pt 1):1045–8.CrossRefGoogle Scholar
  12. 12.
    Poponick JM, Jacobs I, Supinski G, DiMarco AF. Effect of upper respiratory tract infection in patients with neuromuscular disease. Am J Respir Crit Care Med. 1997;156(2):659–64.CrossRefGoogle Scholar
  13. 13.
    Tzeng AC, Bach JR. Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest. 2000;118(5):1390–6.CrossRefGoogle Scholar
  14. 14.
    Bach JR, Rajaraman R, Ballanger F, Tzeng AC, Ishikawa Y, Kulessa R, et al. Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use v oxygen therapy on pneumonia and hospitalization rates. Am J Phys Med Rehabil. 1998;77(1):8–19.CrossRefGoogle Scholar
  15. 15.
    Lemay J, Sériès F, Sénéchal M, Maranda B, Maltais F. Unusual respiratory manifestations in two young adults with Duchenne muscular dystrophy. Can Respir J. 2012;19(1):37.CrossRefGoogle Scholar
  16. 16.
    Renard D, Humbertclaude V, Labauge P. Macroglossia in adult Duchenne muscular dystrophy. Acta Neurol Belg. 2010;110(3):288.PubMedGoogle Scholar
  17. 17.
    Barbe F, Quera-Salva M, McCann C, Gajdos P, Raphael J, de Lattre J, et al. Sleep-related respiratory disturbances in patients with Duchenne muscular dystrophy. Eur Respir J. 1994;7(8):1403–8.CrossRefGoogle Scholar
  18. 18.
    Rabinstein AA, Wijdicks EFM. Warning signs of imminent respiratory failure in neurological patients. Semin Neurol. 2003;23(1):97–104.CrossRefGoogle Scholar
  19. 19.
    Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation—a consensus conference report. Chest. 1999;116(2):521–34.Google Scholar
  20. 20.
    Ozsancak A, D’Ambrosio C, Hill NS. Nocturnal noninvasive ventilation. Chest. 2008;133(5):1275–86.CrossRefGoogle Scholar
  21. 21.
    Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet. 2009;374(9685):250–9.CrossRefGoogle Scholar
  22. 22.
    Bach JR. Continuous noninvasive ventilation for patients with neuromuscular disease and spinal cord injury. Semin Respir Crit Care Med. 2002;23(3):283–92.CrossRefGoogle Scholar
  23. 23.
    Bach JR, Alba AS, Saporito LR. Intermittent positive pressure ventilation via the mouth as an alternative to tracheostomy for 257 ventilator users. Chest. 1993;103(1):174–82.CrossRefGoogle Scholar
  24. 24.
    Toussaint M, Steens M, Wasteels G, Soudon P. Diurnal ventilation via mouthpiece: survival in end-stage Duchenne patients. Eur Respir J. 2006;28(3):549–55.CrossRefGoogle Scholar
  25. 25.
    Affeldt J. Roundtable conference on poliomyelitis equipment. New York: National Foundation for Infantile Paralysis-March of Dimes White Plains; 1953.Google Scholar
  26. 26.
    Servera E, Sancho J, Zafra MJ, Catala A, Vergara P, Marin J. Alternatives to endotracheal intubation for patients with neuromuscular diseases. Am J Phys Med Rehabil. 2005;84(11):851–7.CrossRefGoogle Scholar
  27. 27.
    Toussaint M, Chatwin M, Soudon P. Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience. Chron Respir Dis. 2007;4(3):167–77.CrossRefGoogle Scholar
  28. 28.
    Rabinstein A, Wijdicks EF. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology. 2002;59(10):1647–9.CrossRefGoogle Scholar
  29. 29.
    Vianello A, Bevilacqua M, Arcaro G, Gallan F, Serra E. Non-invasive ventilatory approach to treatment of acute respiratory failure in neuromuscular disorders. A comparison with endotracheal intubation. Intensive Care Med. 2000;26(4):384–90.CrossRefGoogle Scholar
  30. 30.
    Vianello A, Corrado A, Arcaro G, Gallan F, Ori C, Minuzzo M, et al. Mechanical insufflation-exsufflation improves outcomes for neuromuscular disease patients with respiratory tract infections. Am J Phys Med Rehabil. 2005;84(2):83–8; discussion 9–91.CrossRefGoogle Scholar
  31. 31.
    Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med. 1997;127(6):450–3.CrossRefGoogle Scholar
  32. 32.
    McKim DA, Road J, Avendano M, Abdool S, Cote F, Duguid N, et al. Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline. Can Respir J. 2011;18(4):197–215.CrossRefGoogle Scholar
  33. 33.
    Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140–7.CrossRefGoogle Scholar
  34. 34.
    Seneviratne J, Mandrekar J, Wijdicks EF, Rabinstein AA. Noninvasive ventilation in myasthenic crisis. Arch Neurol. 2008;65(1):54–8.CrossRefGoogle Scholar
  35. 35.
    Bach JR, Gonçalves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137(5):1033–9.CrossRefGoogle Scholar
  36. 36.
    Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology. 2003;61(2):171–7.CrossRefGoogle Scholar
  37. 37.
    Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM. Early use of non-invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler. 2007;8(3):185–8.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Hariharan Regunath
    • 1
  • Troy Whitacre
    • 2
  • Stevan P. Whitt
    • 3
  1. 1.Divisions of Pulmonary, Critical Care and Infectious Diseases, Department of MedicineUniversity of MissouriColumbiaUSA
  2. 2.Respiratory Therapy ServicesUniversity of Missouri Hospital and ClinicsColumbiaUSA
  3. 3.Division of Pulmonary, Critical Care and Environmental Medicine, Department of MedicineUniversity of MissouriColumbiaUSA

Personalised recommendations